Method for identifying metabotropic glutamate receptor agonists and potentiators

摘要

The present invention is directed to a method of identifying compounds that activate an mGluR2 receptor and are useful in the treatment of neuopsychological disorders, such as schizophrenia, anxiety, panic disorder, and drug withdrawal.